Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, Jemal A, Siegel RL. Breast Cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–41.
Liang Y, Zhang H, Song X, Yang Q. Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Sem Cancer Biol. 2020;60:14–27.
Mao N, Yin P, Li Q, Wang Q, Liu M, Ma H, Dong J, Che K, Wang Z, Duan S, et al. Radiomics nomogram of contrast-enhanced spectral mammography for prediction of axillary lymph node metastasis in breast cancer: a multicenter study. Eur Radiol. 2020;30(12):6732–9.
Zhan C, Hu Y, Wang X, Liu H, Xia L, Ai T. Prediction of axillary lymph node metastasis in breast Cancer using Intra-peritumoral textural transition analysis based on dynamic Contrast-enhanced magnetic resonance imaging. Acad Radiol. 2022;29(Suppl 1):S107–15.
Lyman GH, Giuliano AE, Somerfield MR, Benson AB III, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS III, Edge SB, Galper S. American society of clinical oncology guideline recommendations for Sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23(30):7703–20.
Boughey JC, Moriarty JP, Degnim AC, Gregg MS, Egginton JS, Long KH. Cost modeling of preoperative axillary ultrasound and fine-needle aspiration to guide surgery for invasive breast cancer. Ann Surg Oncol. 2010;17(4):953–8.
Article PubMed Central PubMed Google Scholar
Langer I, Guller U, Berclaz G, Koechli OR, Schaer G, Fehr MK, Hess T, Oertli D, Bronz L, Schnarwyler B, et al. Morbidity of Sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg. 2007;245(3):452–61.
Article PubMed Central PubMed Google Scholar
Van der Noordaa M, Peeters MV, Rutgers E. The intraoperative assessment of Sentinel nodes–Standards and controversies. Breast. 2017;34:S64–9.
Marino MA, Avendano D, Zapata P, Riedl CC, Pinker K. Lymph node imaging in patients with primary breast cancer: concurrent diagnostic tools. Oncologist. 2020;25(2):e231–42.
Ecanow JS, Abe H, Newstead GM, Ecanow DB, Jeske JM. Axillary staging of breast cancer: what the radiologist should know. Radiographics: Rev Publication Radiological Soc North Am Inc. 2013;33(6):1589–612.
Luo Y, Zhao C, Gao Y, Xiao M, Li W, Zhang J, Ma L, Qin J, Jiang Y, Zhu Q. Predicting axillary lymph node status with a nomogram based on breast lesion ultrasound features: performance in N1 breast Cancer patients. Front Oncol. 2020;10:581321.
Article PubMed Central PubMed Google Scholar
Zhang H, Dong Y, Jia X, Zhang J, Li Z, Chuan Z, Xu Y, Hu B, Huang Y, Chang C, et al. Comprehensive risk system based on shear wave elastography and BI-RADS categories in assessing axillary lymph node metastasis of invasive breast Cancer-A multicenter study. Front Oncol. 2022;12:830910.
Article PubMed Central PubMed Google Scholar
Berg WA, Zhang Z, Lehrer D, Jong RA, Pisano ED, Barr RG, Böhm-Vélez M, Mahoney MC, Evans WP, Larsen LH. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307(13):1394–404.
Article CAS PubMed Central PubMed Google Scholar
Vlahiotis A, Griffin B, Stavros AT, Margolis J: Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography. ClinicoEconomics and Outcomes Research: CEOR 2018, 10:157–167.
Rukanskienė D, Veikutis V, Jonaitienė E, Basevičiūtė M, Kunigiškis D, Paukštaitienė R, Čepulienė D, Poškienė L, Boguševičius A. Preoperative axillary ultrasound versus Sentinel lymph node biopsy in patients with early breast cancer. Medicina. 2020;56(3):127.
Article PubMed Central PubMed Google Scholar
Riedel F, Schaefgen B, Sinn H-P, Feisst M, Hennigs A, Hug S, Binnig A, Gomez C, Harcos A, Stieber A. Diagnostic accuracy of axillary staging by ultrasound in early breast cancer patients. Eur J Radiol. 2021;135:109468.
Huang Z, Tian H, Luo H, Yang K, Chen J, Li G, Ding Z, Luo Y, Tang S, Xu J et al. Assessment of oxygen saturation in breast lesions using photoacoustic imaging: correlation with benign and malignant disease. Clin Breast Cancer 2024;24(4).
Steinberg I, Huland DM, Vermesh O, Frostig HE, Tummers WS, Gambhir SS. Photoacoustic clinical imaging. Photoacoustics. 2019;14:77–98.
Article PubMed Central PubMed Google Scholar
Neuschler EI, Butler R, Young CA, Barke LD, Bertrand ML, Böhm-Vélez M, Destounis S, Donlan P, Grobmyer SR, Katzen J, et al. A pivotal study of optoacoustic imaging to diagnose benign and malignant breast masses: A new evaluation tool for radiologists. Radiology. 2018;287(2):398–412.
Menezes GLG, Pijnappel RM, Meeuwis C, Bisschops R, Veltman J, Lavin PT, van de Vijver MJ, Mann RM. Downgrading of breast masses suspicious for Cancer by using optoacoustic breast imaging. Radiology. 2018;288(2):355–65.
Zhu Q, Ricci A, Hegde P, Kane M, Cronin E, Merkulov A, Xu Y, Tavakoli B, Tannenbaum S. Assessment of functional differences in malignant and benign breast lesions and improvement of diagnostic accuracy by using US-guided diffuse optical tomography in conjunction with conventional US. Radiology. 2016;280(2):387–97.
Zhu Q, Cronin EB, Currier AA, Vine HS, Huang M, Chen N, Xu C. Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction. Radiology. 2005;237(1):57–66.
Chen J, Yin Y, Li G, Tian H, Ding Z, Mo S, Xu J, Huang Z, Dong F. Integrated nomogram to predict HER2 expression in breast tumor: Clinical, Ultrasound, and Photoacoustic imaging approaches. European Journal of Cancer (Oxford, England: 1990) 2024, 209:114259.
Koelliker SL, Chung MA, Mainiero MB, Steinhoff MM, Cady B. Axillary lymph nodes: US-guided fine-needle aspiration for initial staging of breast cancer–correlation with primary tumor size. Radiology. 2008;246(1):81–9.
Wolff A, Elizabeth Hale Hammond M, Allison KH, et al. Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology/college of American pathologists clinical practice guideline focused update. J Clin Oncol. 2018;36(20):2105–22.
Article CAS PubMed Google Scholar
Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B, Senn H-J. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast Cancer 2011. Ann Oncol. 2011;22(8):1736–47.
Article CAS PubMed Central PubMed Google Scholar
Allison KH, Hammond MEH, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL, Hayes DF, Lakhani SR, Chavez-MacGregor M, Perlmutter J. Estrogen and progesterone receptor testing in breast cancer: American society of clinical oncology/college of American pathologists guideline update. Arch Pathol Lab Med. 2020;144(5):545–63.
Article CAS PubMed Google Scholar
Hammond MEH, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M. American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of Estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28(16):2784–95.
Article PubMed Central PubMed Google Scholar
Wang M, Zhao L, Wei Y, Li J, Qi Z, Su N, Zhao C, Zhang R, Tang T, Liu S, et al. Functional photoacoustic/ultrasound imaging for the assessment of breast intraductal lesions: preliminary clinical findings. Biomedical Opt Express. 2021;12(3):1236–46.
Akissue de Camargo Teixeira P, Chala LF, Shimizu C, Filassi JR, Maesaka JY, de Barros N. Axillary lymph node sonographic features and breast tumor characteristics as predictors of malignancy: A nomogram to predict risk. Ultrasound Med Biol. 2017;43(9):1837–45.
Xiong J, Zuo W, Wu Y, Wang X, Li W, Wang Q, Zhou H, Xie M, Qin X. Ultrasonography and clinicopathological features of breast cancer in predicting axillary lymph node metastases. BMC Cancer. 2022;22(1):1155.
Article PubMed Central PubMed Google Scholar
Zong Q, Deng J, Ge W, Chen J, Xu D. Establishment of simple nomograms for predicting axillary lymph node involvement in early breast Cancer. Cancer Manage Res. 2020;12:2025–35.
Han D, Shen R, Yue M, Zhao M, Yu Y, Yao J, Liu Y. Relationship between the changes of positivity rate of HER2 expression and the diameter of invasive lesions in early breast cancer and its clinical significance. Pathol Res Pract. 2022;233:153877.
Comments (0)